Indie Roguelike Pathogenic Surges on Steam With 95% Positive Rating
The game's rapid success demonstrates the market appeal of a uniquely themed, highly customizable roguelike that lets players build their own 'ultimate pathogen.'
Reporting from 1 source: Automaton.
Aberrant Labs' Pathogenic, a roguelike twin-stick shooter where players control a pathogen invading a human body, launched on Steam on July 16. It quickly earned an 'Overwhelmingly Positive' user rating with 95% of 990 reviews positive. The game peaked at 5,890 concurrent players on SteamDB. Its high degree of customization through organelle placement and plasmid trees has been praised.
Pathogenic, developed by Aberrant Labs and published by Slug Disco, had a playtest in May 2025 and a demo in October 2025, amassing over 100,000 wishlists before release. The full version launched on July 16. Players control one of seven pathogen types, each with distinct traits, fighting through the human body's immune system. The core mechanic involves slotting organelles into the pathogen's body, with adjacency effects creating synergies. The game also features a permanent plasmid tree per pathogen. Post-launch updates have already addressed balance and graphics. The launch discount runs until July 31.
Synthesized by Yomimono from the 1 cited source below, including Japanese-language reporting where cited, then editorially reviewed before publishing.